57,48 47,50 IVA esclusa

H361

Gangliosidosis (GM2, B variant, type 1) is a fatal, progressive neurodegenerative lysosomal storage disease caused by a deficiency of β-hexosaminidase.

Working days 10

Specifiche

Breeds

Gene

Organ

specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Chromosome

Also known as

Year Published

Informazioni generali

Gangliosidosis (GM2, B variant, type 1) is a fatal, progressive neurodegenerative lysosomal storage disease caused by a deficiency of β-hexosaminidase. The enzyme is composed of a dimer of two subunits α and β encoded by genes HEXA and HEXB. GM2 gangliosidosis can be caused by defects in the genes HEXA (Tays–Sachs disease, B-variant; where only the isoform A is deficient), HEXB (Sandhoff disease, O-variant; where both isoforms are involved). Mutations within the variants of β-hexosaminidase allow a build-up of toxic substances in the nerve cells (mainly neurons). An autosomal recessive mutation in HEXA is observed in the Japanese Chin dog (also known as Japanese Spaniël).

Caratteristiche cliniche

Dogs affected with Gangliosidosis type 1 can show a variety of symptoms including lack of coordination, depression, behavioral changes, head shaking, mental dullness, seizures, blindness, deafness, developmental delay. The disease is progressive and is likely to lead to death within several months. Euthanasia on humane grounds is likely to be considered.

Informazioni aggiuntive

Riferimenti

Pubmed ID: 23266199

Omia ID: 1461

Come funziona?

1. Seleziona il tuo/tuoi prodotto/i

Seleziona un singolo test, un pacchetto CombiBreed o crea il tuo pacchetto personalizzato

2. Raccogli il campione di DNA

Campiona il DNA come indicato nei nostri prodotti e invialo al nostro laboratorio

3. Risultati

Ci occupiamo del tuo DNA con cura e ti forniamo i risultati del test

Prodotti correlati